1. Home
  2. NUTX vs BWAY Comparison

NUTX vs BWAY Comparison

Compare NUTX & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$175.00

Market Cap

729.5M

Sector

Technology

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$19.34

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
BWAY
Founded
2011
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
729.5M
337.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NUTX
BWAY
Price
$175.00
$19.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$252.50
$23.50
AVG Volume (30 Days)
181.0K
74.4K
Earning Date
11-19-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
213.09
EPS
17.98
0.13
Revenue
$981,195,633.00
$49,094,000.00
Revenue This Year
$108.77
$330.76
Revenue Next Year
$3.69
$22.24
P/E Ratio
$9.35
$61.40
Revenue Growth
236.03
27.08
52 Week Low
$28.82
$7.84
52 Week High
$193.00
$19.80

Technical Indicators

Market Signals
Indicator
NUTX
BWAY
Relative Strength Index (RSI) 58.83 66.56
Support Level $162.59 $15.97
Resistance Level $180.76 $19.80
Average True Range (ATR) 13.96 0.79
MACD -1.30 0.23
Stochastic Oscillator 50.71 90.86

Price Performance

Historical Comparison
NUTX
BWAY

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: